Published: 16 October 2020
Author(s): Silvano GALLUS, Antonio CLAVENNA, Alessandra LUGO
Issue: January 2021
Section: Commentary

A paper published in this issue of the European Journal of Internal Medicine shows results from the COVID-19 RISK and Treatments (CORIST) Collaboration Study [1]. The authors analysed data from a large multicentric Italian retrospective observational study based on 3,451 COVID-19 patients - including 576 deaths - to test a recently debated hypothesis: whether hydroxychloroquine (HCQ) can reduce (or prevent) COVID-19 in-hospital mortality [1–3].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.